The type of ATG matters - Natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius

Transplant Immunology

Volumn 18, Issue 2, 2007, Pages 85-87

  Penack, Olaf ^a   Fischer, Lars ^a   Gentilini, Chiara ^a   Nogai, Axel ^a   Muessig, Arne ^a   Rieger, Kathrin ^a   Ganepola, Susanne ^a   Thiel, Eckhard ^a   Uharek, Lutz ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apoptosis; ATG; Lymphoglobulin; NK cells; Thymoglobulin

Indexed keywords

LIPOCORTIN 5; LYMPHOCYTE ANTIBODY; PROPIDIUM IODIDE; THYMOCYTE ANTIBODY;

APOPTOSIS; ARTICLE; CELL DEATH; CELLULAR IMMUNITY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LYMPHOCYTE; NATURAL KILLER CELL; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANNEXIN A5; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; APOPTOSIS; CELL DEATH; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULINS; KILLER CELLS, NATURAL; PROPIDIUM; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY;

EID: 36048960487     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.05.001     Document Type: Article

References (9)

1. Ferrara J.L., and Deeg H.J. Graft-versus-host disease. N Engl J Med 324 10 (1991) 667-674
2. Appelbaum F.R. Haematopoietic cell transplantation as immunotherapy. Nature 411 6835 (2001) 385-389
3. Ruggeri L., Capanni M., Urbani E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 5562 (2002) 2097-2100
4. Giebel S., Locatelli F., Lamparelli T., et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102 3 (2003) 814-819
5. Kroger N., Shaw B., Iacobelli S., et al. Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. Br J Haematol 129 5 (2005) 631-643
6. Hale G., Rebello P., Brettman L.R., et al. Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration. Blood 104 4 (2004) 948-955
7. Lowsky R., Takahashi T., Liu Y.P., et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med 353 13 (2005) 1321-1331
8. Remberger M., and Sundberg B. Rabbit-immunoglobulin G levels in patients receiving Thymoglobulin as part of conditioning before unrelated donor stem cell transplantation. Haematologica 90 7 (2005) 931-938
9. Waller E.K., Langston A.A., Lonial S., et al. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant 9 7 (2003) 460-471